Patent details

Basic Information

Publication number:

EP1893213

PCT Application Number:

PCT/US/2006/021307

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067606285

PCT Publication Number:

WO/2006/132930

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF PYRIMIDYLAMINOBENZAMIDE COMPOUNDS AND IMATINIB FOR TREATING OR PREVENTING PROLIFERATIVE DISEASES

French Title of Invention:

COMBINAISON DE COMPOSES DE PYRIMIDYLAMINOBENZAMIDE ET IMATINIB PERMETTANT DE TRAITER OU DE PREVENIR LES MALADIES PROLIFERATIVES

German Title of Invention:

KOMBINATION AUS PYRIMIDYLAMINOBENZAMID-VERBINDUNGEN UND IMATINIB ZUR BEHANDLUNG ODER VERHINDERUNG PROLIFERATIVER ERKRANKUNGEN

SPC Number:

Dates

Filing date:

02/06/2006

Grant date:

17/02/2010

EP Publication Date:

17/02/2010

PCT Publication Date:

14/12/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/03/2008

EP B1 Publication Date:

17/02/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/06/2014

Expiration date:

02/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/06/2006

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

ALLAND Leila

Address:

United States (US)

2

Name:

MANLEY Paul, W.

Address:

Switzerland (CH)

3

Name:

MESTAN Juergen

Address:

Germany (DE)

Priority

Priority Number:

687758 P

Priority Date:

03/06/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/506;

Filing date	Document type	Number of pages